Local Evaluation of the Saint Francis Ministries Fatherhood FIRE Program

March 31, 2025 updated by: University of Kansas

KS, NE, and TX Fathers, Couples, and Co-parents Whose Children Are Involved in the Child Welfare System Will Gain the Skills and Knowledge to be Better Parents Through Saint Francis Fatherhood FIRE

This study is the local process and impact evaluation for Saint Francis Ministries' Fatherhood FIRE Program.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This project is based on federal legislation that requires evaluation of a program being implemented and delivered by Saint Francis Ministries, a community-based non-profit organization serving children and families. Saint Francis Ministries received federal funds to expand and deliver the Fatherhood FIRE Program to community-based and justice-system involved fathers in their service area. The FIRE program, which stands for Family-Oriented, Interconnected, Resilient, and Essential, aims to promote responsible and positive fatherhood parenting practices and develop and maintain healthy relationships with their partners and other co-parents (e.g., mothers of their children). Evaluation of the program is a condition of Saint Francis Ministries' grant award from the U.S. Department of Health and Human Services. The KU evaluation team at the School of Social Welfare has been contracted by Saint Francis Ministries to conduct the evaluation. The evaluation will be carried out in two parts: 1) a process evaluation and 2 an outcomes evaluation. The process and target populations for both the process and outcomes components are as follows. PROCESS EVALUATION: The process study involves individuals involved in the implementation of the Fatherhood FIRE program at Saint Francis Ministries. Specific populations eligible for inclusion in the process evaluation include: (1) implementation teams facilitating the Fatherhood FIRE program in three states in Saint Francis Ministries service area (Kansas, Nebraska, & Texas), (2) members of the Fatherhood FIRE Data, Assessment, and Dissemination Workgroup, an advisory group comprised of Saint Francis program administrators and the evaluation team charged with planning and overseeing data collection, evaluation, and dissemination efforts, and (3) the evaluation study team. OUTCOMES EVALUATION: Fathers ages 18 and older who are not incarcerated and are enrolled and participating in the Fatherhood FIRE program. To be eligible for inclusion in the evaluation study, program participants must not be incarcerated, have children up to age 24, and may be living with or apart from their children. Eligible participants may be biological parents, adoptive or foster parents, or other caregivers in the parenting role if they have children who meet the age criteria.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
600

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Kansas
      • Lawrence, Kansas, United States, 66045
        • University of Kansas School of Social Welfare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Fathers with children up to 24 year old
  • Fathers participating in the Saint Francis Fatherhood FIRE Program

Exclusion Criteria:

  • Fathers who are incarcerated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Enhanced Treatment Group
Randomized group of participants receiving an enhanced Fatherhood FIRE program.
Behavioral: Enhanced Saint Francis Fatherhood FIRE Program
Fathers receive an enhanced series of pro-parenting, relationship, and economic stability workshops over 16 weeks. Workshop series are based on a diverse curricula including a combination of either 24/7 Dad or Parent Project and Connections to Success and the Nurturing Fathers enhancement program.
Active Comparator: Control Group
Randomized group of participants receiving the 'services as usual' Fatherhood program.
Behavioral: Services as Usual Saint Francis Fatherhood FIRE Program
Fathers receive the services as usual approach which includes a series of pro-parenting, relationship, and economic stability workshops over 13 weeks. Workshop series are based on a diverse curricula including a combination of either 24/7 Dad or Parent Project and Connections to Success.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Healthy relationship and marriage skills
Time Frame: Measurement of the outcome will occur at three-time points: 1) Pre intervention, 2) at program completion an average of 16 weeks after pre-intervention measure, 3) 3-months post program completion
Dads in the enhanced group demonstrate larger and more sustained change in healthy relationship and marriage skills (e.g., compromise and interactional reactivity) than the control group. The measurement tool used to assess this outcome is the Romantic Partner Conflict Scale (Zacchilli, Hendrick, & Hendrick, 2009).
Measurement of the outcome will occur at three-time points: 1) Pre intervention, 2) at program completion an average of 16 weeks after pre-intervention measure, 3) 3-months post program completion
Parenting skills
Time Frame: Measurement of the outcome will occur at three-time points: 1) Pre intervention, 2) at program completion an average of 16 weeks after pre-intervention measure, 3) 3-months post program completion
Dads in the enhanced group demonstrate larger and more sustained change in parenting skills than the control group. The measurement tool used to assess this outcome is the Parenting Sense of Competence Scale (Ohan, Leung, & Jonston, 2000; Johnston & Mash, 1989; Gillmore & Cuskelly, 2008).
Measurement of the outcome will occur at three-time points: 1) Pre intervention, 2) at program completion an average of 16 weeks after pre-intervention measure, 3) 3-months post program completion
Co-parenting skills
Time Frame: Measurement of the outcome will occur at three-time points: 1) Pre intervention, 2) at program completion an average of 16 weeks after pre-intervention measure, 3) 3-months post program completion
Dads in the enhanced group demonstrate larger and more sustained change in co-parenting skills than the control group. The measurement tool used to assess this outcome is the Daily Co-Parenting Scale (D-COP; McDaniel, Teti, & Feinberg, 2017).
Measurement of the outcome will occur at three-time points: 1) Pre intervention, 2) at program completion an average of 16 weeks after pre-intervention measure, 3) 3-months post program completion
Father-child engagement
Time Frame: Measurement of the outcome will occur at three-time points: 1) Pre intervention, 2) at program completion an average of 16 weeks after pre-intervention measure, 3) 3-months post program completion
Dads in the enhanced group demonstrate larger and more sustained change in father/child engagement than the control group. The measurement tool used to assess this outcome is the Inventory of Father Involvement (Hawkins, Bradford, Palkovitz, & Christiansen, 1999).
Measurement of the outcome will occur at three-time points: 1) Pre intervention, 2) at program completion an average of 16 weeks after pre-intervention measure, 3) 3-months post program completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Kansas

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Jared L Barton, PhD, University of Kansas

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 1, 2022

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 30, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 30, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
October 1, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 15, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 28, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 3, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 31, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 146802

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified data will be archived at the end of the study through an accessible archiving site.

IPD Sharing Time Frame

Data will become available at the end of the study anticipated September 2025

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings